Latest News & Features
Americas
Sandoz has entered into a development and commercialisation agreement with pharmaceutical company Durect to develop the drug Posimir. 10 May 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a ruling of a district court which favoured Cadila Healthcare and Zydus in a patent dispute against Shire. 10 May 2017
Americas
Sanofi and Regeneron have filed the latest round of their appeal to the US Court of Appeals for the Federal Circuit in a bid to stop an injunction against Praluent. 9 May 2017
Americas
Four generic companies have pushed a district court to dismiss competition allegations against them, stating that the latest amendments made by American Sales Company in a class action complaint are “purely cosmetic” and add no new factual allegations. 9 May 2017
Americas
Michael Best & Friedrich has strengthened its IP team with the addition of Mircea Tipescu as a partner in the firm’s IP practice in Chicago. 9 May 2017
Americas
Baxalta, a wholly-owned subsidiary of Shire, has filed a patent infringement complaint against Genentech and Chugai Pharmaceutical. 8 May 2017
Americas
The US Court of Appeals for the Federal Circuit has reversed and remanded a ruling by a district court in a patent dispute between pharmaceutical company Braintree Laboratories and Breckenridge Pharmaceutical. 8 May 2017
article
The English High Court has concluded that a supplementary protection certificate challenged by Sandoz is valid, dismissing the dispute. 5 May 2017
Africa
The World Health Organization will launch a pilot project for biosimilars to make costly cancer treatments more widely available in low and middle income countries. 5 May 2017
Americas
The US Patent and Trademark Office won a case against biotech company NantKwest yesterday at the US Court of Appeals for the Federal Circuit. 4 May 2017